Director/PDMR Shareholding
20 May 2022 16:00 BST Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announces that, on 19 May 2022, it was notified of a transaction in the Company's American Depositary Shares (ADSs) by Aradhana Sarin, Chief Financial Officer and Director of the Company, as set out below. Two ADSs are equivalent to one of the Company's ordinary shares of $0.25 each. PDMR Position Nature of the transaction Quantity PriceAradhana Chief Sale of ADSs 18,095 US$64.56Sarin Financial Officer Further